Leukemia Inhibitory Factor: Part of a Large Ingathering Family

References

• Ishikawa Y. Differentiation of a cell line of myeloid leukemia. J. Cell Physiol. 1969; 74: 223–34
   PubMed Web of Science ®Google Scholar
• Metcalf D., Hilton D. J., Nicola N. A. Clonal variation in susceptibility to differentiation by different protein inducers in the myeloid leukemia cell line MI. Leukemia 1988; 2: 216–21
   PubMed Web of Science ®Google Scholar
• Shabo Y., Lotem J., Rubinstein M., Revel M., Clark S. C., Wolf S. F., Kamen R., Sachs L. The myeloid blood cell differentiation-inducing protein MGI-2A is IL-6. Blood 1988; 72: 2070–73
   PubMed Web of Science ®Google Scholar
• Tomida M., Yamamoto-Yamaguchi Y., Hozumi M. Purification of a factor inducing differentiation of mouse myeloid leukemic Ml cells from conditioned medium of mouse fibroblast L929 cells. J. Biol. Chem. 1984; 259: 10978–82
   PubMed Web of Science ®Google Scholar
• Abe T., Murakami M., Sato T., Kajiki M., Olino M., Kodaira R. Macrophage differentiation inducing factor from human monocytic cells is equivalent to murine LIF. J. Biol. Chem. 1989; 264: 8941–8945
   PubMed Web of Science ®Google Scholar
• Lipton J. H., Sachs L. Characterization of macrophage and granuiocyte inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascities tumor. Biochem. Biophys. Acta 1981; 673: 552–69
   PubMedGoogle Scholar
• Hilton D. J., Nicola N. A., Metcalf D. Purification of a murine leukemia inhibitory factor from Krebs ascites cells. Anal. Biochem. 1988; 173: 359–67
   PubMed Web of Science ®Google Scholar
• Simpson R. J., Hilton D. J., Nice E. C., Rubira M. R., Metcalf D., Gearing D. P., Gough N. M., Nicola N. A. Structural characterization of a murine myeloid leukemia inhibitory factor. Eur. J. Biochem. 1988; 175: 541–47
   PubMedGoogle Scholar
• Gearing D. P., Gough N. M., King J. A., Hilton D. J., Nicola N. A., Simpson R. J., Nice E. C., Kelso A., Metcalf D. Molecular cloning and expression of a cDNA encoding a murine myeloid Leukemia Inhibitory Factor. EMBO J. 1987; 6: 3995–4002
   PubMed Web of Science ®Google Scholar
• Gearing D. P., King J. A., Gough N. M. Complete sequence of murine leukemia inhibitory factor. Nucleic Acid Res. 1988; 16: 9857
   PubMed Web of Science ®Google Scholar
• Ythier A., Abbud-Filho M., Williams J. M., Loertscher R., Schuster M. W., Nowill A., Hansen J. A., Maltezos D., Strom T. Interleukin 2 dependent release of IL3 activity by T4+ human T-cell clones. Proc. Natl. Acad. Sci. USA 1985; 82: 7020–24
   PubMed Web of Science ®Google Scholar
• Moreau J. F., Bonneville M., Peyrat M. A., Jacques Y., Soulillou J. P. Capacity of alloreactive human T cell clones to produce factor(s) inducing proliferation of the IL3-dependent DA-1 murine cell line. Ann. Inst. Pasteur Immunol. 1986; 137C: 25–37
   PubMedGoogle Scholar
• Moreau J. F., Bonneville M., Godard A., Gascan H., Gruart V., Moore M. A., Soulillou J. P. Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. J. Immunol. 1987; 138: 3844–49
   PubMed Web of Science ®Google Scholar
• Godard A., Gascan H., Naulet J., Peyrat M. A., Jacques Y., Soulillou J. P., Moreau J. F. Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 1988; 71: 1618–23
   PubMed Web of Science ®Google Scholar
• Moreau J. F., Donaldson D. D., Bennett F., Witek-Giannotti J. A., Clark S. C., Wong G. G. Leukemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 1988; 336: 690–692
   PubMed Web of Science ®Google Scholar
• Smith A. G., Heath J. K., Donaldson D. D., Wong G. G., Moreau J. F., Stahl M., Rogers D. Inhibition of pluripotential embryonic stem cells differentiation by purified polypeptides. Nature 1988; 336: 688–690
   PubMed Web of Science ®Google Scholar
• Gough N. M., Gearing D. P., King J. A., Willson T. A., Hilton D. J., Nicola N. A., Metcalf D. Molecular cloning and expression of the human homologue of the murine gene encoding myeloid Leukemia Inhibitory Factor. Proc. Natl. Acad. Sci. USA 1988; 88: 2623–27
   Google Scholar
• Koopman P., Cotton R. G.H. A factor produced by feeder cells which inhibits embryonal carcinoma cell differentiation. Characterization and partial purification. Exp. Cell Res. 1984; 154: 233–42
   PubMed Web of Science ®Google Scholar
• Williams R. L., Hilton D. J., Pease S., Willson T. A., Stewart C. L., Gearing D. P., Wagner E. F., Metcalf D., Nicola N. A., Gough N. M. Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988; 336: 684–87
   PubMed Web of Science ®Google Scholar
• Heath J. K. Can there be life without LIF?. Nature 1992; 359: 17
   PubMed Web of Science ®Google Scholar
• Yamamori T., Fukada K., Aebersold R., Korsching S., Fann M. J., Patterson P. H. The Cholinergic Neuronal Differentiation Factor from heart cells is identical to Leukemia Inhibitory Factor. Science 1989; 246: 1412–16
   PubMedGoogle Scholar
• Schotzinger R., Yin X., Landis S. Target determination of neurotransmitter phenotype in sympathetic neurons. J. Neurobiol. 1994; 25: 620–39
   PubMedGoogle Scholar
• Abe E., Tanaka H., Ishimi Y., Miyaura C., Hayashi T., Nagasawa H., Tomida M., Yamaguchi Y., Hozumi M., Suda T. Differentiation Inducing Factor purified from conditioned medium of mitogen-treated spleen cultures stimulates bone resorption. Proc. Natl. Acad. Sci. USA 1986; 83: 5958–62
   PubMed Web of Science ®Google Scholar
• Cornish J., Callon K., King A., Edgar S., Reid I. R. The effect of leukemia inhibitory factor on bone in vivo. Endocrinology 1993; 132: 1359–1366
   PubMed Web of Science ®Google Scholar
• Mori M., Yamaguchi K., Abe K. Purification of a lipoprotein lipase inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem. Biophys. Res. Commun. 1989; 160: 1085–92
   PubMed Web of Science ®Google Scholar
• Marshall M. K., Doerrler W., Feingold K. R., Grunfeld C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology 1994; 135: 141–7
   PubMed Web of Science ®Google Scholar
• Austin L., Bower J., Kurek J., Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J. Neurol. Sci. 1992; 112: 185–91
   PubMed Web of Science ®Google Scholar
• Bower J., Vakakis N., Nicola N. A., Austin L. Specific binding of leukemia inhibitory factor to murine myoblasts in culture. J. cell. Physiol. 1995; 164: 93–8
   PubMed Web of Science ®Google Scholar
• Maley M. A., Davies M. J., Grounds M. D. Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp. cell. Res. 1995; 219: 169–79
   PubMed Web of Science ®Google Scholar
• Kushima Y., Hatanaka H. Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord. Neurosci. Lett. 1992; 143: 110–4
   PubMed Web of Science ®Google Scholar
• Matsui Y., Toksoz D., Nishikawa S., Nishikawa S. I., Williams D., Zsebo K., Hogan B. L. M. Effect of Steel Factor and leukemia inhibitory factor on murine primordial germ cells in culture. Nature 1991; 353: 750–752
   PubMed Web of Science ®Google Scholar
• De Felici M., Dolci S. Leukemia Inhibitory Factor sustains the survival of mouse primordial germ cells cultured on TM4 feeder layers. Dev. Biol. 1991; 147: 281–84
   PubMed Web of Science ®Google Scholar
• Matsui Y., Zsebo K., Hogan B. L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992; 70: 841–7
   PubMed Web of Science ®Google Scholar
• de Miguel M. P., de Boer-Brouwer M., Paniagua R., van den Hurk R., de Rooooij D., van Dissel-Emiliani F. M. F. LIF and CNTF promote the survival of Sertoli cells and gonocytes in a culture system. Endocrinology 1996; 137: 1885–93
   PubMed Web of Science ®Google Scholar
• Estrov Z., Talpaz M., Wetzler M., Kurzrock R. The modulatory hematopoietic activities of leukemia inhibitory factor. Leuk. Lymphoma. 1992; 8: 1–7
   PubMed Web of Science ®Google Scholar
• Akita S., Webster J., Ren S. G., Takino H., Said J., Zand O., Melmed S. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J. Clin. Invest. 1995; 95: 1288–98
   PubMed Web of Science ®Google Scholar
• Benigni F., Fantuzzi G., Sacco S., Sironi M., Pozzi P., Dinarello C. A., Sipe J. D., Poli V., Cappelletti M., Paonessa G., Pennica D., Panayotatos N., Ghezzi P. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood 1996; 87: 1851–4
   PubMed Web of Science ®Google Scholar
• Ferrara N., Winer J., Henzel W. J. Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: identification as leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA 1992; 89: 698–702
   PubMed Web of Science ®Google Scholar
• Gillett N. A., Lowe D., Lu L., Chan C., Ferrara N. Leukemia inhibitory factor expression in human carotid plaques: possible mechanism for inhibition of large vessel endothelial regrowth. Growth Factors 1993; 9: 301–5
   PubMed Web of Science ®Google Scholar
• Grosset C., Jazwiec B., Taupin J. L., Liu H., Richard S., Mahon F. X., Reiffers J., Moreau J. F., Ripoche J. In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. Blood 1995; 86: 3763–70
   PubMed Web of Science ®Google Scholar
• Baumann H., Wong G. G. Hepatocyte Stimulating Factor III shares structural and functional identity with Leukemia Inhibitory Factor. J. Immunol. 1989; 143: 1163–1167
   PubMed Web of Science ®Google Scholar
• Mirshahi S. S., Vasse M., Soria C., Moreau J. F., Taupin J. L., Mirshahi M., Pujade-Lauraine E., Bernadou A., Soria J. Incubation of monocytes with adriamycin increases secretion of hepatocyte stimulating factor for fibrinogen biosynthesis. Blood Coagulation & Fibrinolysis 1993; 4: 149–152
   PubMed Web of Science ®Google Scholar
• Richards C. D., Brown T. J., Shoyab M., Baumann H., Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 1992; 148: 1731–6
   PubMed Web of Science ®Google Scholar
• Mayer P., Geissler K., Ward M., Metcalf D. Recombinant human leukemia inhibitory factor induces acute phase proteins and raises the blood platelet counts in nonhuman primates. Blood 1993; 81: 3226–33
   PubMed Web of Science ®Google Scholar
• Pierzchalski P., Rokita H., Koj A., Fries E., Akerstrom B. Synthesis of alpha 1-microglobulin in cultured rat hepatocytes is stimulated by interleukin-6, leukemia inhibitory factor, dexamethasone and retinoic acid. FEBS Lett. 1992; 298: 165–8
   PubMed Web of Science ®Google Scholar
• Le P. T., Lazorick S., Whichard L. P., Yang Y. C., Clark C. S., Haynes B. F., Singer K. H. Human thymic epithelial cells produce IL-6, Granulocyte-Monocyte-CSF, and Leukemia Inhibitory Factor. J. Immunol. 1990; 145: 3310–15
   PubMed Web of Science ®Google Scholar
• Sakata T., Iwagami S., Tsuruta Y., Yamaguchi M., Michishita M., Nagata K., Takai Y., Ogata M., Teraoka H., Fujiwara H. Constitutive expression of leukemia inhibitory factor (LIF) mRNA and production of LIF by a cloned murine thymic stromal cell line. Thymus 1992; 19: 89–95
   PubMedGoogle Scholar
• Escary J. L., Perreau J., Dumenil D., Ezine S., Brulet P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 1993; 363: 361–4
   PubMed Web of Science ®Google Scholar
• Shen M. M., Skoda R. C., Cardiff R. D., Campos-Torres J., Leder P., Ornitz D. M. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J. 1994; 13: 1375–85
   PubMed Web of Science ®Google Scholar
• Gascan H., Godard A., Ferenz C., Naulet J., Praloran V., Peyrat M. A., Hewick R., Jacques Y., Moreau J. F., Soulillou J. P. Characterization and amino-terminal aminoacid sequence of natural human interleukin for DA cells/leukemia inhibitory factor. J. Biol. Chem. 1989; 264: 21509–15
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Nicola N. A., Metcalf D., Foote S., Willson T. A., Gough N. M., Williams R. L. Production of leukemia inhibitory factor in E. coli by a novel procedure and its use in maintaining embryonic stem cells in culture. Biotechnology 1989; 7: 1157–1161
   Google Scholar
• Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659–66
   PubMed Web of Science ®Google Scholar
• Lowe D. G., Nunes W., Bombara M., Mc Cabe S., Ranges G. E., Henzel W., Tomida M., Yamamoto-Yamaguchi Y., Hozumi M., Goeddel D. V. Genomic cloning and heterologous expression of human differentiation-stimulating factor. DNA 1989; 8: 351–59
   PubMedGoogle Scholar
• Hallet M. ML, Peyrat M. A., Soulillou J. P., Moreau J. F. Simultaneous transcription of eleven cytokines in human alloreactive T lymphocyte clones after stimulation by phorbol ester and A23187. Eur. Cytokine Netw. 1992; 3: 477–83
   PubMedGoogle Scholar
• Hamilton J. A., Waring P. M., Filonzi E. L. Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J. Immunol. 1993; 150: 1496–502
   PubMed Web of Science ®Google Scholar
• Campbell I. K., Waring P., Novak U., Hamilton J. A. Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum. 1993; 36: 790–4
   PubMedGoogle Scholar
• Lorenzo J. A., Jastrzebski S. L., Kalinowski J. F., Downie E., Korn J. H. Tumor necrosis factor alpha stimulates production of leukemia inhibitory factor in human dermal fibroblast cultures. Clin. Immunol. Immunopathol. 1994; 70: 260–5
   PubMedGoogle Scholar
• Dechanet J., Taupin J. L., Chomarat P., Rissoan M. C., Moreau J. F., Banchereau J., Miossec P. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur. J. Immunol. 1994; 24: 3222–8
   PubMed Web of Science ®Google Scholar
• Ulich T. R., del Castillo J., Shin S. S., Yin S., Duryea D., Tarpley J., Samal B. Hematologic effects of stem cell factor (SCF) and leukemia inhibitory factor (LIF) in vivo: LIF-induced thrombocytosis in SCF-primed mice. Eur. J. Haematol. 1995; 54: 217–25
   PubMed Web of Science ®Google Scholar
• Wetzler M., Estrov Z., Talpaz M., Kim K. J., Alphonso M., Srinivasan R., Kurzrock R. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha. Cancer Res. 1994; 54: 1837–42
   PubMed Web of Science ®Google Scholar
• Lecron J. C., Roblot P., Chevalier S., Morel F., Alderman E., Gombert J., Gascan H. High circulating LIF in patients with giant cell arteritis: independent regulation of LIF and IL6 under corticosteroid therapy. Clin. Exp. Immunol. 1993; 92: 23–26
   PubMed Web of Science ®Google Scholar
• Bentouimou N., Moreau J. F., Peyrat M. A., Soulillou J. P., Hallet M. M. The effects of cyclosporine on HILDA/LIF gene expression in human T cells. Transplantation 1993; 55: 163–67
   PubMed Web of Science ®Google Scholar
• Imamura M., Zhu X., Hashino S., Han C. W., Tanaka J., Kobayashi H., Imai K., Kasai M., Sakurada K., Miyazaki T. Effects of 15-deoxyspergualin on proliferative responses and cytokine gene expression in vitro. Immunobiology 1994; 192: 27–39
   Web of Science ®Google Scholar
• Wetzler M., Kurzrock R., Estrov Z., Estey E., Talpaz M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk. Res. 1995; 19: 23–34
   PubMed Web of Science ®Google Scholar
• Sutherland G. R., Baker E., Hyland V. J., Callen D. F., Stahl J., Gough N. M. The gene for leukemia inhibitory factor (LIF) maps to 22q12. Leukemia. 1989; 3: 9–13
   PubMed Web of Science ®Google Scholar
• Pergolizzi R. G., Erster S. H. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus. Mol. Chem. Neuropathol. 1994; 21: 189–217
   PubMedGoogle Scholar
• Kola I., Davey A., Gough N. A. Localization of the murine leukemia inhibitory factor gene near the centromere on chromosome 11. Growth Factors 1990; 2: 235–40
   PubMed Web of Science ®Google Scholar
• Bottorff D., Stone J. C. The murine leukemia inhibition factor gene (LIF) is located on proximal chromosome 11, not chromosome 13. Mamm. Genome 1992; 3: 681–4
   PubMed Web of Science ®Google Scholar
• Budarf M., Emanuel B. S., Mohandas T., Goeddel D. V., Lowe D. G. Human differentiation-stimulating factor (leukemia inhibitory factor, human interleukin DA) gene maps distal to the Ewing sarcoma breakpoint on 22q. Cytogenet. Cell Genet. 1989; 52: 19–22
   PubMedGoogle Scholar
• Stahl J., Gearing D. P., Willson T. A., Brown M. A., King J. A., Gough N. M. Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions. J. Biol. Chem. 1990; 265: 8833–41
   PubMed Web of Science ®Google Scholar
• Stahl J., Gough N. M. Delineation of positive and negative control elements within the promoter region of the murine leukemia inhibitory factor (LIF) gene. Cytokine 1993; 5: 386–93
   PubMed Web of Science ®Google Scholar
• Bruce A. G., Linsley P. S., Rose T. M. Oncostatin M. Progress in Growth Factor Research 1992; 4: 157–70
   PubMedGoogle Scholar
• Giovannini M., Selleri L., Hermanson G. G., Evans G. A. Localization of the human oncostatin M gene (OSM) to chromosome 22q12, distal to the Ewing's sarcoma breakpoint. Cytogenet. Cell Genet. 1993; 62: 32–4
   PubMedGoogle Scholar
• Jeffery E., Price V., Gearing D. P. Close proximity of the genes for leukemia inhibitory factor and oncostatin M. Cytokine 1993; 5: 107–11
   PubMed Web of Science ®Google Scholar
• Giovannini M., Djabali M., McElligott D., Selleri L., Evans G. A. Tandem linkage of genes coding for leukemia inhibitory factor (LIF) and oncostatin M (OSM) on human chromosome 22. Cytogenet. Cell Genet. 1993; 64: 240–4
   PubMedGoogle Scholar
• Rose T. M., Lagrou M. J., Fransson I., Werelius B., Delattre O., Thomas G., de Jong P. J., Todaro G. J., Dumanski J. P. The genes for oncostatin M (OSM) and leukemia inhibitory factor (LIF) are tightly linked on human chromosome 22. Genomics 1993; 17: 136–40
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Bruce A. G. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor. New Biologist 1992; 4: 61–5
   PubMedGoogle Scholar
• Liu J., Modrell B., Aruffo A., Scharnowske S., Shoyab M. Interactions between OSM and the IL6 signal transducer, gp130. Cytokine 1994; 6: 272–78
   PubMed Web of Science ®Google Scholar
• Rathjen P. D., Toth S., Willis A., Heath J. K., Smith A. G. Differentiation inhibiting activity/leukemia inhibitory factor (DIA/LIF) is produced in matrix-associated and diffusible forms generated by alternate promoter usage. Cell 1990; 62: 1105–1114
   PubMed Web of Science ®Google Scholar
• Willson T. A., Metcalf D., Gough N. M. Cross-species comparison of the sequence of the leukemia inhibitory factor gene and its protein. Eur. J. Biochem. 1992; 204: 21–30
   PubMedGoogle Scholar
• Robertson M., Chambers L., Rathjen P., Nichols J., Smith A. Expression of alternative forms of differentiation inhibiting activity (DIA/LIF) during murine embryogenesis and in neonatal and adult tissues. Dev. Genet. 1993; 14: 165–73
   PubMedGoogle Scholar
• Conquet F., Peyrieras N., Tiret L., Brulet P. Inhibited gastrulation in mouse embryos over-expressing the leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA 1992; 89: 8195–19
   PubMed Web of Science ®Google Scholar
• Shen M. M., Leder P. Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc. Natl. Acad. Sci. USA 1992; 89: 8240–4
   PubMed Web of Science ®Google Scholar
• Gupta P., McCarthy J. B., Verfaillie C. M. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 1996; 87: 3229–36
   PubMed Web of Science ®Google Scholar
• Tomida M., Yamamoto-Yamaguchi Y., Hozumi M. Three different cDNAs encoding mouse D-factor/LIF receptor. J. Biochem. 1994; 115: 557–62
   PubMed Web of Science ®Google Scholar
• Tomida M. Analysis of recombinant soluble mouse D-factor/LIF receptor. J. Biochem. 1995; 117: 1228–31
   PubMed Web of Science ®Google Scholar
• Owczarek C. M., Layton M. J., Robb L. G., Nicola N. A., Begley C. G. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor alpha-chain. Expression in normal, gestating, and leukemia inhibitory factor nullizygous mice. J. Biol. Chem. 1996; 271: 5495–504
   PubMed Web of Science ®Google Scholar
• Mereau A., Grey L., Piquet-Pellorce C., Heath J. K. Characterization of a binding protein for leukemia inhibitory factor localized in extracellular matrix. J. Cell. Biol. 1993; 122: 713–9
   PubMed Web of Science ®Google Scholar
• Layton M. J., Cross B. A., Metcalf D., Ward L. D., Simpson R. J., Nicola N. A. A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. Proc. Natl. Acad. Sci. USA 1992; 89: 8616–20
   PubMed Web of Science ®Google Scholar
• Nicola N. A., Cross B., Simpson R. J. The disulfide bond arrangement of leukemia inhibitory factor: homology to oncostatin M and structural implications. Biochem. Biophys. Res. Comm. 1993; 190: 20–6
   PubMed Web of Science ®Google Scholar
• Betzel C., Visanji M., Dauter Z., Fourme R., Weber W., Marnitz U., Boone T., Pope J., Miller J., Hawkins N. Crystallization and preliminary X-ray analysis of leukemia inhibitory factor. FEBS Lett. 1993; 336: 236–8
   PubMed Web of Science ®Google Scholar
• Smith D. K., Treutlein H. R., Maurer T., Owczarek C. M., Layton M. J., Nicola N. A., Norton R. S. Homology modelling and 1H NMR studies of human leukaemia inhibitory factor. FEBS Lett. 1994; 350: 275–80
   PubMed Web of Science ®Google Scholar
• Robinson R. C., Grey L. M., Staunton D., Vankelecom H., Vernallis A. B., Moreau J. F., Stuart D. I., Heath J. K., Jones E. Y. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell 1994; 77: 1101–16
   PubMed Web of Science ®Google Scholar
• Maurer T., Smith D. K., Owczarek C. M., Layton M. J., Zhang J. G., Nicola N. A., Norton R. S. NMR studies of a murine-human chimera of LIF. Comparison with human LIF. Growth Factors 1994; 11: 271–6
   PubMed Web of Science ®Google Scholar
• de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992; 255: 306–312
   PubMed Web of Science ®Google Scholar
• Bazan J. F. Neuropoietic cytokines in the hematopoietic fold. Neuron 1991; 7: 197–208
   PubMed Web of Science ®Google Scholar
• Hill C. P., Osslund T. D., Eisenberg D. The structure of granulocyte colony stimulating factor and its relationship to other growth factors. Proc. Natl. Acad. Sci. USA 1993; 90: 5167–5171
   PubMed Web of Science ®Google Scholar
• Godard A., Heymann D., Raher S., Anegon I., Peyrat M. A., Le Mauff B., Mouray E., Gregoire M., Virdee K., Soulillou J. P., Moreau J. F., Jacques Y. High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. J. Biol. Chem. 1992; 267: 3214–22
   PubMed Web of Science ®Google Scholar
• Hartner A., Goppelt-Strube M., Hocke G., Fey G., Sterzel R. B. Renal mesangial cells have the capacity to synthetize and react to LIF. Ann. NY Acad. Sci. 1995; 762: 424–5
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Nicola N. A., Metcalf D. Distribution and comparison of the receptors for LIF on murine hemopoietic and hepatic Cells. J. Cell Physiol. 1991; 146: 207–215
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Nicola N. A. Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution. J. Biol. Chem. 1992; 267: 10238–47
   PubMed Web of Science ®Google Scholar
• Sasaki H., Hirabayashi Y., Ishibashi T., Inoue T., Matsuda M., Kai S., Ikuta K., Yokoyama K., Yokota T., Maruyama Y. Effects of Epo, IL3, IL6 and LIF on a murine megakaryoblastic cell line: growth enhancement and expression of receptor mRNAs. Leuk. Res. 1995; 19: 95–102
   PubMed Web of Science ®Google Scholar
• Van Damme J., Uyttenhove C., Houssiau F., Put W., Proost P., Van Snick J. Human growth factor for murine interleukin IL9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA. Eur. J. Immunol. 1992; 22: 2801–8
   PubMed Web of Science ®Google Scholar
• Zhang X. G., Gu J. J., Lu Z. Y., Yasukawa K., Yancopoulos G. D., Turner K., Shoyab M., Taga T., Kishimoto T., Bataille R., Klein B. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med. 1994; 179: 1337–42
   PubMed Web of Science ®Google Scholar
• Nishimoto N., Ogata A., Shima Y., Tani Y., Ogawa H., Nakagawa M., Sugiyama H., Yoshizaki K., Kishimoto T. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J. Exp. Med. 1994; 179: 1343–7
   PubMed Web of Science ®Google Scholar
• Mattei S., Colombo M. P., Melani C., Silvani A., Parmiani G., Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int. J. Cancer 1994; 56: 853–7
   PubMed Web of Science ®Google Scholar
• Gu Z. J., Costes V., Lu Z. Y., Zhang X. G., Pitard V., Moreau J. F., Bataille R., Wijdenes J., Rossi J. F., Klein B. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood 1996; 88: 3972–3986
   PubMed Web of Science ®Google Scholar
• Bellido T., Stahl N., Farruggella T. J., Borba V., Yancopoulos G. D., Manolagas S. C. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J. Clin. Invest. 1996; 97: 431–7
   PubMed Web of Science ®Google Scholar
• Kamohara H., Sakamoto K., Ishiko T., Mita S., Masuda Y., Abe T., Ogawa M. Human carcinoma cell lines produce biologically active leukemia inhibitory factor (LIF). Res. Commun. Mol. Pathol. Pharmacol. 1994; 85: 131–40
   PubMedGoogle Scholar
• Takanashi M., Motoji T., Masuda M., Oshimi K., Mizoguchi H. The effects of leukemia inhibitory factor and interleukin 6 on the growth of acute myeloid leukemia cells. Leuk. Res. 1993; 17: 217–22
   PubMed Web of Science ®Google Scholar
• Portier M., Zhang X. G., Ursule E., Lees D., Jourdan M., Bataille R., Klein B. Cytokine gene expression in human multiple myeloma. Br. J. Haematol. 1993; 85: 514–20
   PubMed Web of Science ®Google Scholar
• Estrov Z., Samal B., Lapushin R., Kellokumpu-Lehtinen P., Sahin A. A., Kurzrock R., Talpaz M., Aggarwal B. B. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J Interferon. Cytokine Res. 1995; 15: 905–13
   Google Scholar
• Kellokumpu-Lehtinen P., Talpaz M., Harris D., Van Q., Kurzrock R., Estrov Z. Leukemia inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int. J. Cancer 1996; 66: 515–9
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Thut C. J., VandenBos T., Gimpel S. D., Delaney P. B., King J., Price V., Cosman D., Beckmann M. P. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 1991; 10: 2839–48
   PubMed Web of Science ®Google Scholar
• Gough N. M. Molecular genetics of LIF and its receptor. Growth Factors 1992; 7: 175–9
   PubMed Web of Science ®Google Scholar
• Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B., Ziegler S. F., Cosman D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434–7
   PubMed Web of Science ®Google Scholar
• Nicola N. A., Robb L., Metcalf D., Cary D., Drinkwater C. C., Begley G. Functional inactivation in mice of the gene for the IL3-specific receptor beta-chain: implications for IL3 function and the mechanism of the receptor transmodulation in hematopoietic cells. Blood 1996; 87: 2665–74
   PubMed Web of Science ®Google Scholar
• Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. IL2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73: 147–57
   PubMed Web of Science ®Google Scholar
• Bazan J. F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, IL6 and erythropoietin receptors, and the p75 IL2 receptor beta-chain. Biochem. Biophys. Res. Commun. 1989; 164: 788–796
   PubMed Web of Science ®Google Scholar
• Bazan J. F. Haematopoietic receptors and helical cytokines. Immunol. Today 1990; 11: 350–354
   PubMedGoogle Scholar
• Ip N. Y., Nye S. H., Boulton T. G., Davis S., Taga T., Li Y., Birren S. J., Yasukawa K., Kishimoto T., Anderson D. J., Stahl N., Yancopoulos G. D. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69: 1121–32
   PubMed Web of Science ®Google Scholar
• Taga T., Narazaki M., Yasukawa K., Saito T., Miki D., Hamaguchi M., Davis S., Shoyab M., Yancopoulos G. D., Kishimoto T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 1992; 89: 10998–1001
   PubMed Web of Science ®Google Scholar
• Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993; 260: 1808–10
   PubMed Web of Science ®Google Scholar
• Stahl N., Davis S., Wong V., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component. J. Biol. Chem. 1993; 268: 7628–31
   PubMed Web of Science ®Google Scholar
• Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N Y., Yancopoulos G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1993; 260: 1805–8
   PubMed Web of Science ®Google Scholar
• Stahl N., Boulton T. G., Farruggella T., Ip N. Y., Davis S., Witthuhn B. A., Quelle F. W., Silvennoinen O., Barbieri G., Pellegrini S., Ihle J. N., Yancopoulos G. D. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 1994; 263: 92–5
   PubMed Web of Science ®Google Scholar
• Thoma B., Bird T. A., Friend D. J., Gearing D. P., Dower S. K. Oncostatin M and Leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem. 1994; 269: 6215–22
   PubMed Web of Science ®Google Scholar
• Narazaki M., Witthuhn B. A., Yoshida K., Silvennoinen O., Yasukawa K., Ihle J. N., Kishimoto T., Taga T. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 1994; 91: 2285–9
   PubMed Web of Science ®Google Scholar
• Feldman M., Petricoin E. F., David M., Larner A. C., Finbloom D. S. Cytokines that associate with the signal transducer gp130 activate the interferon-induced transcription factor p91 by tyrosine phosphorylation. J. Biol. Chem. 1994; 269: 10747–52
   PubMed Web of Science ®Google Scholar
• Ernst M., Gearing D. P., Dunn A. R. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 1994; 13: 1574–84
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Hilton A. A., Raicevic A., Rakar S., Harrison-Smith M., Gough N. M., Begley C. G., Metcalf D., Nicola N. A., Willson T. A. Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 1994; 13: 4765–75
   PubMed Web of Science ®Google Scholar
• Kalberg C., Yung S. Y., Kessler J. A. The cholinergic stimulating effects of ciliary neurotrophic factor and leukemia inhibitory factor are mediated by protein kinase C. J. Neurochem. 1993; 60: 145–52
   PubMed Web of Science ®Google Scholar
• Yin T., Yang Y. C. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J. Biol. Chem. 1994; 269: 3731–8
   PubMed Web of Science ®Google Scholar
• Schiemann W. P., Nathanson N. M. Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukemia inhibitory factor. Evidence for participation of multiple signaling pathways. J. Biol. Chem. 1994; 269: 6376–82
   PubMed Web of Science ®Google Scholar
• Akira S., Nishio Y., Inoue M., Wang X. J., Wei S., Matsusaka T. K. Y., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 1994; 77: 63–71
   PubMed Web of Science ®Google Scholar
• Boulton T. G., Stahl N., Yancopoulos G. D. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem. 1994; 269: 11648–55
   PubMed Web of Science ®Google Scholar
• Schiemann W. P., Graves L. M., Baumann H., Morella K. K., Gearing D. P., Nielsen M. D., Krebs E. G., Nathanson N. M. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation. Proc. Natl. Acad. Sci. USA 1995; 92: 5361–5
   PubMed Web of Science ®Google Scholar
• Matsuda T., Fukada T., Takahashi-Tezuka M., Okuyama Y., Fujitani Y., Hanazono Y., Hirai H., Hirano T. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J. Biol. Chem. 1995; 270: 11037–9
   PubMed Web of Science ®Google Scholar
• Chauhan D., Kharbanda S. M., Ogata A., Urashima M., Frank D., Malik N., Kufe D. W., Anderson K. C. Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells. J. Exp. Med. 1995; 182: 1801–6
   PubMed Web of Science ®Google Scholar
• Livnah O., Stura E. A., Johnson D. L., Middleton S. A., Mulcahy L. S., Wrighton N. C., Dower W. J., Jolliffe L. K., Wilson I. A. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Science 1996; 273: 464–71
   PubMed Web of Science ®Google Scholar
• Cosman D. The hematopoietin receptor superfamily. Cytokine 1993; 5: 95–106
   PubMed Web of Science ®Google Scholar
• Miyasaki T., Maruyama M., Yamada G., Hatakeyama M., Taniguchi T. The integrity of the conserved “WS motif” common to IL2 and other cytokine receptors is essential for ligand binding and signal transduction. EMBO J. 1991; 10: 3191–97
   PubMed Web of Science ®Google Scholar
• Hilton D. J., Watowich S. S., Katz L., Lodish H. F. Saturation mutagenesis of the WSXWS motif of the erthropoietin receptor. J. Biol. Chem. 1996; 271: 4699–4708
   PubMed Web of Science ®Google Scholar
• Hiraoka O., Anaguchi H., Asakura A., Ota Y. Requirement for the immunoglobulin-like domain of granulocyte colony-stimulating factor receptor in formation of a 2:1 receptor-ligand complex. J. Biol. Chem. 1996; 270: 25928–34
   Web of Science ®Google Scholar
• Tomida M., Yamamoto-Yamaguchi Y., Hozumi M. Pregnancy associated increase in mRNA for soluble D-factor/LIF receptor in mouse liver. FEBS Lett. 1993; 334: 193–7
   PubMed Web of Science ®Google Scholar
• Yamaguchi-Yamamoto Y., Tomida M., Hozumi M. Pregnancy associated increase in differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF)-binding substance(s) in mouse serum. Leuk. Res. 1993; 17: 515–22
   PubMed Web of Science ®Google Scholar
• Baumann H., Ziegler S. F., Mosley B., Morella K. K., Pajovic S., Gearing D. P. Reconstitution of the response to LIF, OSM, and CNTF in hepatoma cells. J. Biol. Chem. 1992; 268: 8414–17
   Google Scholar
• Heymann D., Godard A., Raher S., Bentouimou S., Blanchard F., Cherel M., Hallet M. M., Jacques Y. Leukemia Inhibitory Factor and Oncostatin M high affinity binding require additional receptor subunits besides gp130 and gp190. Cytokine 1996; 8: 197–205
   PubMed Web of Science ®Google Scholar
• Mosley B., Deimus C., Friend D., Thoma B., Cosman D. The OSM receptor: cloning of a novel subunit related to the LIF receptor (Abstract A92). Cytokine 1994; 6: 554
   Google Scholar
• Sporeno E., Paonessa G., Salvati A. L., Graziani R., Delmastro P., Ciliberto G., Toniatti C. OSM binds directly to gp130 and behaves as IL6 antagonist on a cell line expressing gp130 but lacking functional OSM receptors. J. Biol. Chem. 1994; 269: 10991–95
   PubMed Web of Science ®Google Scholar
• Layton M. J., Lock P., Metcalf D., Nicola N. A. Cross-species receptor binding characteristics of human and mouse leukemia inhibitory factor suggest a complex binding interaction. J. Biol. Chem. 1994; 269: 17048–55
   PubMed Web of Science ®Google Scholar
• Owczarek C. M., Layton M. J., Metcalf D., Lock P., Willson T. A., Gough N. M., Nicola N. A. Inter-species chimeras of leukaemia inhibitory factor define a major human receptor-binding determinant. EMBO J. 1993; 12: 3487–95
   Google Scholar
• Layton M. J., Owczarek C. M., Metcalf D., Clark R. L., Smith D. K., Treutlein H. R., Nicola N. A. Conversion of the biological specificity of murine to human leukemia inhibitory factor by replacing 6 amino acid residues. J. Biol. Chem. 1994; 269: 29891–6
   PubMed Web of Science ®Google Scholar
• Cunningham B. C., Wells J. A. Comparison of a structural and functional epitope. Mol. Biol. 1993; 234: 5554–63
   Web of Science ®Google Scholar
• Ciapponi L., Graziani R., Paonessa G., Lahm A., Ciliberto G., Savino R. Definition of a composite binding site for gp130 in human interleukin-6. J. Biol. Chem. 1995; 270: 31249–54
   PubMed Web of Science ®Google Scholar
• Metcalf D., Gearing D. P. Fatal syndrome in mice engrafted with cells producing high levels of LIF. Proc. Natl. Acad. Sci. USA 1989; 86: 5948–52
   PubMed Web of Science ®Google Scholar
• Metcalf D., Gearing D. P. A myelosclerotic syndrome in mice engrafted with cells producing high levels of LIF. Leukemia 1990; 3: 847–52
   Web of Science ®Google Scholar
• Metcalf D., Nicola N. A., Gearing D. P. Effects of injected LIF on hematopoietic and other tissues in mice. Blood 1990; 76: 50–6
   PubMed Web of Science ®Google Scholar
• Waring P., Wycherley K., Cary D., Nicola N., Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J. Clin. Invest. 1992; 90: 2031–7
   PubMed Web of Science ®Google Scholar
• Brown M. A., Metcalf D., Gough N. M. Leukaemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation. Cytokine 1994; 6: 300–9
   PubMed Web of Science ®Google Scholar
• Feingold K. R., Marshall M., Gulli R., Moser A. H., Grunfeld C. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler. Thromb. 1994; 14: 1866–72
   PubMedGoogle Scholar
• Villers D., Dao T., Nguyen J. M., Birbnneau E., Godard A., Moreau M., De Groote D., Nicolas F., Soulillou J. P., Anegon I. Increased plasma levels of human interleukin for DALa cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis. J. Infect. Dis. 1995; 171: 232–6
   PubMed Web of Science ®Google Scholar
• Waring P. M., Waring L. J., Billington T., Metcalf D. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc. Natl Acad. Sci. USA 1995; 92: 1337–41
   PubMed Web of Science ®Google Scholar
• Waring P. M., Waring L. J., Metcalf D. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. J. Infect. Dis. 1994; 170: 1224–8
   PubMed Web of Science ®Google Scholar
• Alexander H. R., Wong G. G., Doherty G. M., Venzon D. J., Fraker D. L., Norton J. A. Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor. J. Exp. Med. 1992; 175: 1139–42
   PubMed Web of Science ®Google Scholar
• Jansen P. M., de Jong I. W., Hart M., Jin Kim K., Aarden L. A., Hinshaw L. B., Taylor F. B., Hack E. Release of LIF in primate sepsis. Analysis of the role of TNF alpha. J. Immunol. 1996; 156: 4401–07
   PubMed Web of Science ®Google Scholar
• Waring P. M., Romero R., Laham N., Gomez R., Rice G. E. Leukemia inhibitory factor: association with intraamniotic infection. Am. J. Obstet. Gynecol. 1994; 171: 1335–41
   PubMed Web of Science ®Google Scholar
• Ulich T. R., Fann M. J., Patterson P. H., Williams J. H., Samal B., Del Castillo J., Yin S., Guo K., Remick D. G. Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am. J. Physiol. 1994; 267: L442–6
   PubMed Web of Science ®Google Scholar
• Block M. I., Berg M., McNamara M. J., Norton J. A., Fraker D. L., Alexander H. R. Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J. Exp. Med. 1993; 178: 1085–90
   PubMed Web of Science ®Google Scholar
• Ray D. W., Ren S., Melmed S. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J. Clin. Invest. 1996; 97: 1852–9
   PubMed Web of Science ®Google Scholar
• Villiger P. M., Terkeltaub R., Lotz M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J. Clin. Invest. 1992; 90: 488–96
   PubMed Web of Science ®Google Scholar
• Musso T., Badolato R., Longo D. L., Gusella G. L., Varesio L. Leukemia inhibitory factor induces interleukin-8 and monocyte chemotactic and activating factor in human monocytes: differential regulation by interferon-gamma. Blood 1995; 86: 1961–7
   PubMed Web of Science ®Google Scholar
• Jorens P. G., de Jongh R., Bossaert L. L., de Backer W., Herman A. G., Pollet H., Bosmans E., Taupin J. L., Moreau J. F. High levels of LIF in ARDS. Cytokine 1996; 8: 873–876
   PubMed Web of Science ®Google Scholar
• Taupin J. L., Morel D., Moreau J. F., Gualde N., Potaux L., Bezian J. H. HILDA/LIF urinary excretion during acute kidney rejection. Transplantation 1992; 53: 655–58
   PubMed Web of Science ®Google Scholar
• Blancho G., Moreau J. F., Anegon I., Soulillou J. P. HILDA/LIF is present in the urine of rejecting kidney graft recipients. Transpl. Int. 1992; 5: 57–8
   PubMed Web of Science ®Google Scholar
• Blancho G., Moreau J. F., Chabannes D., Chatenoud L., Soulillou J. P. HILDA/LIF, G. CSF, IL-1 beta, IL-6, and TNF alpha production during acute rejection of human kidney allografts. Transplantation 1993; 56: 597–602
   PubMed Web of Science ®Google Scholar
• Blancho G., Moreau J. F., Chabannes D., Chatenoud L., Soulillou J. P. Human interleukin DA-la HILDA/LIF,G-CSF, IL-1 beta, IL-6, and TNF alpha production during acute kidney graft rejection episodes. Transplant. Proc. 1993; 25: 891–2
   PubMed Web of Science ®Google Scholar
• Morel D., Taupin J. L., Combe C., Potaux L., Gualde N., Moreau J. F. One-year enzyme-linked immunosorbent assay follow-up of human interleukin for Da cells/leukemia inhibitory factor in blood and urine of 22 kidney transplant recipients. Transplantation 1994; 58: 1190–5
   PubMed Web of Science ®Google Scholar
• Verfaillie C., McGlave P. LIF/HILDA: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors. Blood 1991; 77: 263–70
   PubMed Web of Science ®Google Scholar
• Leary A. G., Zeng H. Q., Clark S. C., Ogawa M. Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc. Natl. Acad. Sci. USA 1992; 89: 4013–7
   PubMed Web of Science ®Google Scholar
• Verfaillie C. M. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993; 82: 2045–53
   PubMed Web of Science ®Google Scholar
• Yamaguchi M., Miki N., Ono M., Ohtsuka C., Demura H., Kurachi H., Inoue M., Endo H., Taga T., Kishimoto T., Miyake A. Inhibition of growth hormone-releasing factor production in mouse placenta by cytokines using gp130 as a signal transducer. Endocrinology 1995; 136: 1072–8
   PubMed Web of Science ®Google Scholar
• Stewart C. L., Kaspar P., Brunet L. J., Bhatt H., Gadi I., Kontgen F., Abbondanzo S. J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76–9
   PubMed Web of Science ®Google Scholar
• Schaafsma M. R., Falkenburg J. H., Duinkerken N., Moreau J. F., Soulillou J. P., Willemze R., Fibbe W. E. Human interleukin for DA cells (HILDA) does not affect the proliferation and differentiation of hematopoietic progenitor cells in human long-term bone marrow cultures. Exp. Hematol. 1992; 20: 6–10
   PubMed Web of Science ®Google Scholar
• Firkin F. C., Birner R., Farag S. Differential action of diffusible molecules in long-term marrow culture on proliferation of leukaemic and normal haemopoietic cells. Br. J. Haematol. 1993; 84: 8–15
   PubMed Web of Science ®Google Scholar
• Debili N., Masse J. M., Katz A., Guichard J., Breton-Gorius J., Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood 1993; 82: 84–95
   PubMed Web of Science ®Google Scholar
• Gabutti V., Timeus F., Ramenghi U., Crescenzio N., Marranca D., Miniero R., Cornaglia G., Bagnara G. P. Expansion of cord blood progenitors and use for hemopoietic reconstitution. Stem cells 1993; 11(Suppl.)105–12
   PubMedGoogle Scholar
• Szilvassy S. J., Cory S. Efficient retroviral gene transfer to purified longterm repopulating hematopoietic stem cells. Blood 1994; 84: 74–83
   PubMed Web of Science ®Google Scholar
• Szilvassy S. J., Weller K. P., Lin W., Sharma A. K., Ho A. S., Tsukamoto A., Hoffman R., Leiby K. R., Gearing D. P. Leukemia inhibitory factor upreguiates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells. Blood 1996; 87: 4618–28
   PubMed Web of Science ®Google Scholar
• Ware C. B., Horowitz M. C., Renshaw B. R., Hunt J. S., Liggitt D., Koblar S. A., Gliniak B. C., McKenna H. J., Papayannopoulou T., Thoma B., Cheng L., Donovan P. J., Peschon J. J., Bartlett P. F., Willis C. R., Wright B. D., Carpenter M. K., Davison B. L., Gearing D. P. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995; 121: 1286–99
   Web of Science ®Google Scholar
• Li M., Sendtner M., Smith A. Essential function of LIF receptor in motor neurons. Nature 1995; 378: 724–27
   PubMed Web of Science ®Google Scholar
• Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T., Hirabayashi T., Yoneda Y., Tanaka K., Wang W. Z., Mori C., Shiota K., Yoshida N., Kishimoto T. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 1996; 93: 407–11
   PubMed Web of Science ®Google Scholar
• Pennica D., King K. L., Shaw K. J., Luis E., Rullamas J., Luoh S. M., Darbonne W. C., Knutzon D. S., Yen R., Chien K. R., Baker J. B., Wood W. I. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 1995; 92: 1142–6
   PubMed Web of Science ®Google Scholar
• Pennica D., Shaw K. J., Swanson T. A., Moore M. W., Shelton D. L., Zioncheck K. A., Rosenthal A., Taga T., Paoni N. F., Wood W. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 1995; 270: 10915–22
   PubMed Web of Science ®Google Scholar
• Sheng Z., Pennica D., Wood W. I., Chien K. R. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 1996; 122: 419–28
   PubMed Web of Science ®Google Scholar
• Wollert K. C., Taga T., Saito M., Narazaki M., Kishimoto T., Glembotski C. C., Vernallis A. B., Heath J. K., Pennica D., Wood W. I., Chien K. R. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J. Biol. Chem. 1996; 271: 9535–45
   PubMed Web of Science ®Google Scholar
• Ryffel B. Pathology induced by leukemia inhibitory factor. Int. Rev. Exp. Pathol. 1993; 34: 69–72
   PubMedGoogle Scholar
• Villiger P. M., Geng Y., Lotz M. Induction of cytokine expression by leukemia inhibitory factor. J. Clin. Invest. 1993; 91: 1575–81
   Google Scholar
• Waring P., Wall D., Dauer R., Parkin D., Metcalf D. The effects of leukaemia inhibitory factor on platelet function. Brit. J. Haematol. 1993; 83: 80–87
   PubMed Web of Science ®Google Scholar
• Farese A. M., Myers L. A., MacVittie T. J. Therapeutic efficacy of recombinant human leukemia inhibitory factor in primate model of radiation induced marrow aplasia. Blood 1994; 84: 3675–8
   PubMed Web of Science ®Google Scholar
• Block M. I., Fraker D. L., Strassmann G., Billingsley K. G., Arnold W. S., Perils C., Alexander H. R. Endogenous D-factor activity partially mediates the toxic but not the therapeutic effects of tumor necrosis factor. Int. J. Cancer. 1995; 63: 245–9
   PubMed Web of Science ®Google Scholar
• Lal R. B., Rudolph D., Buckner C., Pardi D., Hooper W. C. Infection with human T-lyipphotropic viruses leads to constitutive expression of LIF anf IL6. Blood 1993; 81: 1827–32
   PubMed Web of Science ®Google Scholar
• Broor S., Kusari A. B., Zhang B., Seth P., Richman D. D., Carson D. A., Wachsman W., Lotz M. Stimulation of HIV replication in mononuclear phagocytes by leukemia inhibitory factor. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1994; 7: 647–54
   Google Scholar
• Moran C. S., Campbell J. H., Simmons D. L., Campbell G. R. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis. Arterioscler. Thromb. 1994; 14: 1356–63
   PubMedGoogle Scholar
• Marusic A., Kalinowski J. F., Jastrzebski S., Lorenzo J. A. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells. J. Bone. Miner. Res. 1993; 8: 617–24
   PubMed Web of Science ®Google Scholar
• Kirby M. L., Kumiski D. H., Myers T., Cerjan C., Mishima N. Back-transplantation of chick cardiac neural crest cells cultured in LIF rescues heart development. Dev. Dyn. 1993; 198: 296–311
   PubMed Web of Science ®Google Scholar
• Barnard W., Bower J., Brown M. A., Murphy M., Austin L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: Injured muscle expresses LIF mRNA. J. Neurol. Sci. 1994; 123: 108–113
   PubMed Web of Science ®Google Scholar
• Papaxanthos-Roche A., Taupin J. L., Mayer G., Daniel J. Y., Moreau J. F. Human interleukin for DA cells or leukemia inhibitory factor is released by Vero cells in human embryo coculture. Fertil. Steril. 1994; 62: 648–50
   PubMed Web of Science ®Google Scholar
• Sawai K., Matsuzaki N., Kameda T., Hashimoto K., Okada T., Shimoya K., Nobunaga T., Taga T., Kishimoto T., Saji F. Leukemia inhibitory factor produced at the fetomaternal interface stimulates chorionic gonadotropin production: its possible implication during pregnancy, including implantation period. J. Clin. Endocrinol. Metab. 1995; 80: 1449–56
   PubMed Web of Science ®Google Scholar
• Leary A. G., Wong G. G., Clark S. C., Smith A. G., Ogawa M. LIF/DIA/HILDA augments proliferation of human hematopoietic stem cells. Blood 1990; 75: 1960–64
   PubMed Web of Science ®Google Scholar
• Fletcher F. A., Williams D. E., Maliszewski C., Anderson D., Rives M., Belmont J. W. Murine LIF enhances retroviral-vector infection efficiency of hematopoietic progenitors. Blood 1990; 76: 1098–1103
   PubMed Web of Science ®Google Scholar
• Fletcher F. A., Moore K. A., Ashkenazi M., de Vries P., Overbeek P. A., Williams D. E., Belmont J. W. LIF improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J. Exp. Med. 1991; 174: 837–845
   PubMed Web of Science ®Google Scholar
• Moore K. A., Deisseroth A. B., Reading C. L., Williams D. E., Belmont J. W. Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 1992; 79: 1393–99
   PubMed Web of Science ®Google Scholar
• Burstein S. A., Mei R. L., Henthorn J., Friese P., Turner K. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J. cell. Physiology 1992; 153: 305–12
   PubMed Web of Science ®Google Scholar
• Gimble J. M., Wanker F., Wang C. S., Bass H., Wu X., Kelly K., Yancopoulos G. D., Hill M. R. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein. J. cell. Biochem. 1994; 54: 122–33
   PubMed Web of Science ®Google Scholar